Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2026-05-11 @ 11:28 PM
Study NCT ID:
NCT00349934
Status:
COMPLETED
Last Update Posted:
2010-01-07
First Post:
2006-07-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
IMP321 Plus First-line Paclitaxel in Metastatic Breast Carcinoma
Sponsor:
Immutep S.A.S.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
P005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
F. Triebel, Chief Medical Officer
Old Organization:
Immutep S.A.
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |